<VariationArchive VariationID="496920" VariationName="NM_206933.2(USH2A):c.8179dup (p.Val2727Glyfs)" VariationType="Duplication" Accession="VCV000496920" Version="8" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="4" DateLastUpdated="2024-03-05" DateCreated="2018-04-02" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="488344" VariationID="496920">
      <GeneList>
        <Gene Symbol="USH2A" FullName="usherin" GeneID="7399" HGNC_ID="HGNC:12601" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q41</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="215622891" stop="216423448" display_start="215622891" display_stop="216423448" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="215796235" stop="216596737" display_start="215796235" display_stop="216596737" Strand="-" />
          </Location>
          <OMIM>608400</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_206933.2(USH2A):c.8179dup (p.Val2727Glyfs)</Name>
      <CanonicalSPDI>NC_000001.11:215888469:CCCC:CCCCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>1q41</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="215888469" stop="215888470" display_start="215888469" display_stop="215888470" variantLength="1" positionVCF="215888469" referenceAlleleVCF="A" alternateAlleleVCF="AC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="216061811" stop="216061812" display_start="216061811" display_stop="216061812" variantLength="1" positionVCF="216061811" referenceAlleleVCF="A" alternateAlleleVCF="AC" />
      </Location>
      <ProteinChange>V2727fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_206933.2" sequenceAccession="NM_206933" sequenceVersion="2" change="c.8179dup">
            <Expression>NM_206933.2:c.8179dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.216061815dup" Assembly="GRCh37">
            <Expression>NC_000001.10:g.216061815dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.215888473dup" Assembly="GRCh38">
            <Expression>NC_000001.11:g.215888473dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009497.2" sequenceAccession="NG_009497" sequenceVersion="2" change="g.539979dup">
            <Expression>NG_009497.2:g.539979dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_206933.4" sequenceAccession="NM_206933" sequenceVersion="4" change="c.8179dup" MANESelect="true">
            <Expression>NM_206933.4:c.8179dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_996816.3" sequenceAccession="NP_996816" sequenceVersion="3" change="p.Val2727fs">
            <Expression>NP_996816.3:p.Val2727fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_206933.2" sequenceAccession="NM_206933" sequenceVersion="2" change="c.8179dupG">
            <Expression>NM_206933.2:c.8179dupG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA1394668" DB="ClinGen" />
        <XRef Type="rs" ID="774573692" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_206933.2(USH2A):c.8179dup (p.Val2727Glyfs) AND not provided" Accession="RCV000593419" Version="7">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-10-09" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_206933.2(USH2A):c.8179dup (p.Val2727Glyfs) AND multiple conditions" Accession="RCV000666089" Version="1">
        <ClassifiedConditionList TraitSetID="10164">
          <ClassifiedCondition DB="MedGen" ID="C3151138">Retinitis pigmentosa 39</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1848634">Usher syndrome type 2A</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-03-16" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_206933.2(USH2A):c.8179dup (p.Val2727Glyfs) AND Retinitis pigmentosa 39" Accession="RCV003451339" Version="1">
        <ClassifiedConditionList TraitSetID="595">
          <ClassifiedCondition DB="MedGen" ID="C3151138">Retinitis pigmentosa 39</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-04" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_206933.2(USH2A):c.8179dup (p.Val2727Glyfs) AND Usher syndrome type 2A" Accession="RCV003451338" Version="1">
        <ClassifiedConditionList TraitSetID="594">
          <ClassifiedCondition DB="MedGen" ID="C1848634">Usher syndrome type 2A</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-04" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-04" NumberOfSubmissions="5" NumberOfSubmitters="4" DateCreated="2018-04-02" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10729113</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">10909849</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20507924</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25649381</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=USH2A</URL>
        </Citation>
        <DescriptionHistory Dated="2018-08-13">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2018-08-13">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="595" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9776" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Retinitis pigmentosa 39</ElementValue>
                <XRef ID="Retinitis+pigmentosa+39/9227" DB="Genetic Alliance" />
                <XRef ID="MONDO:0013436" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">RP39</ElementValue>
                <XRef Type="MIM" ID="613809" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15715" />
                <XRef ID="15715" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301590</ID>
                <ID Source="BookShelf">NBK1417</ID>
              </Citation>
              <XRef ID="791" DB="Orphanet" />
              <XRef ID="C3151138" DB="MedGen" />
              <XRef ID="MONDO:0013436" DB="MONDO" />
              <XRef Type="MIM" ID="613809" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="10164" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6097" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">USHER SYNDROME, TYPE IIA</ElementValue>
                <XRef Type="MIM" ID="276901" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0011" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">RETINAL DISEASE IN USHER SYNDROME TYPE IIA, MODIFIER OF</ElementValue>
                <XRef Type="Allelic variant" ID="612971.0001" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Usher syndrome type 2A</ElementValue>
                <XRef ID="MONDO:0010169" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">USH2A</ElementValue>
                <XRef Type="MIM" ID="276901" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">USH2</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">US2</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Usher syndrome type II (USH2) is characterized by the following: Congenital, bilateral sensorineural hearing loss that is mild to moderate in the low frequencies and severe to profound in the higher frequencies. Intact or variable vestibular responses. Retinitis pigmentosa (RP); progressive, bilateral, symmetric retinal degeneration that begins with night blindness and constricted visual fields (tunnel vision) and eventually includes decreased central visual acuity; the rate and degree of vision loss vary within and among families.</Attribute>
                <XRef ID="NBK1341" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15241" />
                <XRef ID="15241" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5440" />
                <XRef ID="5440" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301515</ID>
                <ID Source="BookShelf">NBK1341</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">21697857</ID>
              </Citation>
              <XRef ID="231178" DB="Orphanet" />
              <XRef ID="886" DB="Orphanet" />
              <XRef ID="C1848634" DB="MedGen" />
              <XRef ID="MONDO:0010169" DB="MONDO" />
              <XRef Type="MIM" ID="276901" DB="OMIM" />
            </Trait>
            <Trait ID="9776" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Retinitis pigmentosa 39</ElementValue>
                <XRef ID="Retinitis+pigmentosa+39/9227" DB="Genetic Alliance" />
                <XRef ID="MONDO:0013436" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">RP39</ElementValue>
                <XRef Type="MIM" ID="613809" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15715" />
                <XRef ID="15715" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301590</ID>
                <ID Source="BookShelf">NBK1417</ID>
              </Citation>
              <XRef ID="791" DB="Orphanet" />
              <XRef ID="C3151138" DB="MedGen" />
              <XRef ID="MONDO:0013436" DB="MONDO" />
              <XRef Type="MIM" ID="613809" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="594" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6097" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">USHER SYNDROME, TYPE IIA</ElementValue>
                <XRef Type="MIM" ID="276901" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0011" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">RETINAL DISEASE IN USHER SYNDROME TYPE IIA, MODIFIER OF</ElementValue>
                <XRef Type="Allelic variant" ID="612971.0001" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Usher syndrome type 2A</ElementValue>
                <XRef ID="MONDO:0010169" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">USH2A</ElementValue>
                <XRef Type="MIM" ID="276901" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">USH2</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">US2</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Usher syndrome type II (USH2) is characterized by the following: Congenital, bilateral sensorineural hearing loss that is mild to moderate in the low frequencies and severe to profound in the higher frequencies. Intact or variable vestibular responses. Retinitis pigmentosa (RP); progressive, bilateral, symmetric retinal degeneration that begins with night blindness and constricted visual fields (tunnel vision) and eventually includes decreased central visual acuity; the rate and degree of vision loss vary within and among families.</Attribute>
                <XRef ID="NBK1341" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15241" />
                <XRef ID="15241" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5440" />
                <XRef ID="5440" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301515</ID>
                <ID Source="BookShelf">NBK1341</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">21697857</ID>
              </Citation>
              <XRef ID="231178" DB="Orphanet" />
              <XRef ID="886" DB="Orphanet" />
              <XRef ID="C1848634" DB="MedGen" />
              <XRef ID="MONDO:0010169" DB="MONDO" />
              <XRef Type="MIM" ID="276901" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1540633" SubmissionDate="2018-07-10" DateLastUpdated="2018-08-05" DateCreated="2018-08-05">
        <ClinVarSubmissionID localKey="1345742|OMIM:276901;613809" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000790329" DateUpdated="2018-08-05" DateCreated="2018-08-05" Type="SCV" Version="1" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-03-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Counsyl Autosomal Recessive and X-Linked Classification Criteria (2018)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/sbjulxjt/counsyl_autosomal_recessive_and_x-linked_classification_criteria_2018_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="USH2A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="1" alternateAllele="AC" referenceAllele="A" start="216061811" stop="216061811" variantLength="1" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_206933.2:c.8179dupG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="276901" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613809" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4282047</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1373042" SubmissionDate="2018-09-19" DateLastUpdated="2018-04-02" DateCreated="2018-04-02">
        <ClinVarSubmissionID localKey="15155_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000700640" DateUpdated="2018-04-02" DateCreated="2018-04-02" Type="SCV" Version="2" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <ReplacedList>
          <Replaced Accession="SCV000700641" DateChanged="2019-08-06" Version="1">
            <Comment Type="MergeComment">SCV000700641 was merged into SCV000700640 to remove duplication.</Comment>
          </Replaced>
        </ReplacedList>
        <Classification DateLastEvaluated="2016-11-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/ahdynye1/egl_classification_definitions_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="USH2A" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="1" alternateAllele="CC" referenceAllele="C" start="216061812" stop="216061812" variantLength="1" />
            <GeneLocation>NM_206933.2:Ex41</GeneLocation>
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=USH2A</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>EGL005</SubmissionName>
          <SubmissionName>SUB4534263</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7822853" SubmissionDate="2023-12-17" DateLastUpdated="2023-12-24" DateCreated="2023-12-24">
        <ClinVarSubmissionID localKey="NM_206933.2:c.8179dup|OMIM:613809" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004182836" DateUpdated="2023-12-24" DateCreated="2023-12-24" Type="SCV" Version="1" SubmitterName="Genome-Nilou Lab" OrgID="507598" OrganizationCategory="laboratory" OrgAbbreviation="Genome Nilou" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="USH2A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_206933.2:c.8179dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613809" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14095489</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7822854" SubmissionDate="2023-12-17" DateLastUpdated="2023-12-24" DateCreated="2023-12-24">
        <ClinVarSubmissionID localKey="NM_206933.2:c.8179dup|OMIM:276901" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004182837" DateUpdated="2023-12-24" DateCreated="2023-12-24" Type="SCV" Version="1" SubmitterName="Genome-Nilou Lab" OrgID="507598" OrganizationCategory="laboratory" OrgAbbreviation="Genome Nilou" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="USH2A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_206933.2:c.8179dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="276901" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14095489</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4245798" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="13389697|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002231185" DateUpdated="2024-02-28" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10729113</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10909849</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20507924</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25649381</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Val2727Glyfs*30) in the USH2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with USH2A-related conditions. ClinVar contains an entry for this variant (Variation ID: 496920). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="USH2A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.216061811_216061812insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4245798" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1540633" TraitType="Disease" MappingType="XRef" MappingValue="613809" MappingRef="OMIM">
        <MedGen CUI="C3151138" Name="Retinitis pigmentosa 39" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7822854" TraitType="Disease" MappingType="XRef" MappingValue="276901" MappingRef="OMIM">
        <MedGen CUI="C1848634" Name="Usher syndrome type 2A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1540633" TraitType="Disease" MappingType="XRef" MappingValue="276901" MappingRef="OMIM">
        <MedGen CUI="C1848634" Name="Usher syndrome type 2A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7822853" TraitType="Disease" MappingType="XRef" MappingValue="613809" MappingRef="OMIM">
        <MedGen CUI="C3151138" Name="Retinitis pigmentosa 39" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1373042" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

